RU2018142846A - Характерные наборы биомаркеров системной красной волчанки и их применение - Google Patents
Характерные наборы биомаркеров системной красной волчанки и их применение Download PDFInfo
- Publication number
- RU2018142846A RU2018142846A RU2018142846A RU2018142846A RU2018142846A RU 2018142846 A RU2018142846 A RU 2018142846A RU 2018142846 A RU2018142846 A RU 2018142846A RU 2018142846 A RU2018142846 A RU 2018142846A RU 2018142846 A RU2018142846 A RU 2018142846A
- Authority
- RU
- Russia
- Prior art keywords
- measuring
- test sample
- sle
- biomarkers
- biomarkers shown
- Prior art date
Links
- 239000000090 biomarker Substances 0.000 title claims 60
- 206010025135 lupus erythematosus Diseases 0.000 title 1
- 238000000034 method Methods 0.000 claims 41
- 239000000523 sample Substances 0.000 claims 34
- 230000001575 pathological effect Effects 0.000 claims 23
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 12
- 239000012634 fragment Substances 0.000 claims 11
- 239000011230 binding agent Substances 0.000 claims 8
- 239000013068 control sample Substances 0.000 claims 8
- 208000024891 symptom Diseases 0.000 claims 4
- 230000005713 exacerbation Effects 0.000 claims 3
- 238000002965 ELISA Methods 0.000 claims 2
- 108060003951 Immunoglobulin Proteins 0.000 claims 1
- 230000002255 enzymatic effect Effects 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 102000018358 immunoglobulin Human genes 0.000 claims 1
- 238000002493 microarray Methods 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 230000002285 radioactive effect Effects 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/104—Lupus erythematosus [SLE]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Rehabilitation Therapy (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1609951.7 | 2016-06-07 | ||
| GBGB1609951.7A GB201609951D0 (en) | 2016-06-07 | 2016-06-07 | Biomarkers signatures and uses thereof |
| PCT/EP2017/063855 WO2017211896A1 (en) | 2016-06-07 | 2017-06-07 | Biomarker signatures of systemic lupus erythematosus and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2018142846A true RU2018142846A (ru) | 2020-07-09 |
| RU2018142846A3 RU2018142846A3 (enExample) | 2020-09-16 |
Family
ID=56508210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018142846A RU2018142846A (ru) | 2016-06-07 | 2017-06-07 | Характерные наборы биомаркеров системной красной волчанки и их применение |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20200041504A1 (enExample) |
| EP (1) | EP3465209A1 (enExample) |
| JP (1) | JP2019526810A (enExample) |
| KR (1) | KR20190038791A (enExample) |
| CN (1) | CN109690312A (enExample) |
| AU (1) | AU2017277583A1 (enExample) |
| BR (1) | BR112018075223A2 (enExample) |
| CA (1) | CA3026574A1 (enExample) |
| GB (1) | GB201609951D0 (enExample) |
| MX (1) | MX2018015140A (enExample) |
| RU (1) | RU2018142846A (enExample) |
| WO (1) | WO2017211896A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201014837D0 (en) | 2010-09-07 | 2010-10-20 | Immunovia Ab | Biomarker signatures and uses thereof |
| WO2020081204A1 (en) * | 2018-10-18 | 2020-04-23 | Oklahoma Medical Research Foundation | Biomarkers for a systemic lupus erythematosus (sle) disease activity immune index that characterizes disease activity |
| GB201904472D0 (en) * | 2019-03-29 | 2019-05-15 | Immunovia Ab | Methods, arrays and uses thereof |
| CN118948243B (zh) * | 2024-07-23 | 2025-10-17 | 中国医科大学附属第一医院 | 基于机器学习对神经精神狼疮进行影像组学诊断的方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0039578B1 (en) | 1980-05-02 | 1985-04-10 | Edward P. Davis | Leg aid device |
| US4486530A (en) | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US5856090A (en) | 1994-09-09 | 1999-01-05 | The Scripps Research Institute | DNA-methylase linking reaction |
| GB9703369D0 (en) | 1997-02-18 | 1997-04-09 | Lindqvist Bjorn H | Process |
| US20070141627A1 (en) * | 2005-10-19 | 2007-06-21 | Behrens Timothy W | Systemic Lupus Erythematosus |
| GB201014837D0 (en) * | 2010-09-07 | 2010-10-20 | Immunovia Ab | Biomarker signatures and uses thereof |
| WO2014008426A2 (en) * | 2012-07-06 | 2014-01-09 | Ignyta, Inc. | Diagnosis of systemic lupus erythematosus |
| US20160223537A1 (en) * | 2013-09-11 | 2016-08-04 | Singapore Health Services Pte Ltd | Identification of novel biomarkers of flares of systemic lupus erythematosus |
| GB201319878D0 (en) * | 2013-11-11 | 2013-12-25 | Immunovia Ab | Method, Array and use thereof |
| GB201410226D0 (en) * | 2014-06-09 | 2014-07-23 | Immunovia Ab | Methods and arrays for use in the same |
| CA2997838A1 (en) * | 2014-10-07 | 2016-04-14 | University Health Network | Urinary biomarkers for sle and lupus nephritis |
-
2016
- 2016-06-07 GB GBGB1609951.7A patent/GB201609951D0/en not_active Ceased
-
2017
- 2017-06-07 RU RU2018142846A patent/RU2018142846A/ru not_active Application Discontinuation
- 2017-06-07 AU AU2017277583A patent/AU2017277583A1/en not_active Abandoned
- 2017-06-07 JP JP2019517154A patent/JP2019526810A/ja active Pending
- 2017-06-07 BR BR112018075223-1A patent/BR112018075223A2/pt not_active IP Right Cessation
- 2017-06-07 CN CN201780035793.2A patent/CN109690312A/zh active Pending
- 2017-06-07 CA CA3026574A patent/CA3026574A1/en not_active Abandoned
- 2017-06-07 KR KR1020197000245A patent/KR20190038791A/ko not_active Ceased
- 2017-06-07 WO PCT/EP2017/063855 patent/WO2017211896A1/en not_active Ceased
- 2017-06-07 MX MX2018015140A patent/MX2018015140A/es unknown
- 2017-06-07 EP EP17733373.9A patent/EP3465209A1/en not_active Withdrawn
- 2017-06-07 US US16/308,275 patent/US20200041504A1/en not_active Abandoned
-
2022
- 2022-06-23 US US17/848,365 patent/US20230063017A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017211896A9 (en) | 2019-03-14 |
| US20200041504A1 (en) | 2020-02-06 |
| JP2019526810A (ja) | 2019-09-19 |
| EP3465209A1 (en) | 2019-04-10 |
| MX2018015140A (es) | 2019-08-16 |
| US20230063017A1 (en) | 2023-03-02 |
| GB201609951D0 (en) | 2016-07-20 |
| AU2017277583A1 (en) | 2019-01-03 |
| WO2017211896A1 (en) | 2017-12-14 |
| KR20190038791A (ko) | 2019-04-09 |
| CN109690312A (zh) | 2019-04-26 |
| AU2017277583A9 (en) | 2019-08-01 |
| CA3026574A1 (en) | 2017-12-14 |
| BR112018075223A2 (pt) | 2019-03-19 |
| RU2018142846A3 (enExample) | 2020-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dähnrich et al. | Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy | |
| Csernok et al. | Evaluation of automated multi-parametric indirect immunofluorescence assays to detect anti-neutrophil cytoplasmic antibodies (ANCA) in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) | |
| Savige et al. | International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA) | |
| RU2018142846A (ru) | Характерные наборы биомаркеров системной красной волчанки и их применение | |
| JP2016507066A5 (enExample) | ||
| JP2010522875A5 (enExample) | ||
| RU2013151081A (ru) | Иммуноферментный анализ | |
| ATE449337T1 (de) | Assay | |
| RU2011125320A (ru) | Способы, устройства и наборы для детекции или мониторинга острого повреждения почек | |
| WO2013132347A3 (en) | Improved elisa immunoassay for calprotectin | |
| WO2011101487A1 (en) | Method and system for disease diagnosis via simultaneous detection of antibodies bound to synthetic and cellular substrates | |
| CA2747253A1 (en) | Method and kit for use in the differentiation of ibd and ibs and further distinction between disease types of ibd | |
| CA2690718A1 (en) | Device, kit and method for hookworm antigen capture and detection | |
| RU2018103933A (ru) | Моноклональные антитела, с ориентировкой на антиген Р респираторно-синцитиального вируса человека, получаемые и секретируемые из клеточных гибридом, используемые для обнаружения и диагностики инфекции, вызываемой респираторно-синцитиальным вирусом | |
| KR20130083810A (ko) | 류마티스 관절염 진단 키트 | |
| DK2406633T3 (en) | COMPOSITIONS AND PROCEDURES FOR CHARACTERIZING ARTHRITIC CONDITIONS | |
| RU2019113127A (ru) | REP белок в качестве белкового антигена для диагностических анализов | |
| EA202092454A1 (ru) | Способы и композиции для количественного определения il-33 | |
| Devreese | Noncriteria antiphospholipid antibodies in antiphospholipid syndrome | |
| HRP20201418T1 (hr) | Postupak dijagnoze zaraznog peritonitisa i predviđanje težine i ishoda istog kod ljudi | |
| Gudipati et al. | Immunohistochemical analysis of anti-phospholipase A2 receptor antibody on renal biopsies: a single tertiary care center Study | |
| JP2008503737A5 (enExample) | ||
| Caster et al. | Precision medicine in lupus nephritis: can biomarkers get us there? | |
| GB2590230A (en) | Methods and kits for detection of 11-dehydro-thromboxane B2 | |
| JP2014224759A5 (enExample) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20210601 |